110 likes | 298 Views
“Crohn's Disease - Pipeline Review, H2 2014”, provides an overview of the Crohn's Diseases therapeutic pipeline. For more details : http://goo.gl/1kdcXk
E N D
Aarkstore - Crohns Disease - Pipeline Review, H2 2014 www.aarkstore.com
Summary “Crohn's Disease - Pipeline Review, H2 2014”, provides an overview of the Crohn's Diseases therapeutic pipeline. This Market Research Report provides comprehensive information on the therapeutic development for Crohn's Disease, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Crohn's Disease and special features on late-stage and discontinued projects. www.aarkstore.com
Scope - The report provides a snapshot of the global therapeutic landscape of Crohn's Disease- The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities - The report reviews key players involved in the therapeutics development for Crohn's Disease and enlists all their major and minor projects- The report summarizes all the dormant and discontinued pipeline projects - A review of the Crohn's Disease products under development by companies and universities/research institutes based on information derived from company and industry-specific sources- Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages- A detailed assessment of monotherapy and combination therapy pipeline projects- Coverage of the Crohn's Disease pipeline on the basis of target, MoA, route of administration and molecule type- Latest news and deals relating related to pipeline products www.aarkstore.com
Reasons to buy - Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage- Develop strategic initiatives by understanding the focus areas of leading companies- Identify and understand important and diverse types of therapeutics under development for Crohn's Disease- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline- Devise corrective measures for pipeline projects by understanding Crohn's Disease pipeline depth and focus of Indication therapeutics- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and Scope- Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline www.aarkstore.com
Table of Contents Introduction 12Global Markets Direct Report Coverage 12Crohn's Disease Overview 13Therapeutics Development 14Pipeline Products for Crohn's Disease - Overview 14Pipeline Products for Crohn's Disease - Comparative Analysis 15Crohn's Disease - Therapeutics under Development by Companies 16Crohn's Disease - Therapeutics under Investigation by Universities/Institutes 24Crohn's Disease - Pipeline Products Glance 25Late Stage Products 25Clinical Stage Products 26Early Stage Products 27 www.aarkstore.com
List Of Tables Number of Products under Development for Crohn's Disease, H2 2014 22Number of Products under Development for Crohn's Disease - Comparative Analysis, H2 2014 23Number of Products under Development by Companies, H2 2014 25Number of Products under Development by Companies, H2 2014 (Contd..1) 26Number of Products under Development by Companies, H2 2014 (Contd..2) 27Number of Products under Development by Companies, H2 2014 (Contd..3) 28Number of Products under Development by Companies, H2 2014 (Contd..4) 29Number of Products under Development by Companies, H2 2014 (Contd..5) 30Number of Products under Development by Companies, H2 2014 (Contd..6) 31Number of Products under Investigation by Universities/Institutes, H2 2014 32 www.aarkstore.com
List Of Figures Number of Products under Development for Crohn's Disease, H2 2014 22Number of Products under Development for Crohn's Disease - Comparative Analysis, H2 2014 23Number of Products under Development by Companies, H2 2014 24Number of Products under Investigation by Universities/Institutes, H2 2014 32Comparative Analysis by Late Stage Development, H2 2014 33Comparative Analysis by Clinical Stage Development, H2 2014 34Comparative Analysis by Early Stage Products, H2 2014 35Assessment by Monotherapy Products, H2 2014 126Assessment by Combination Products, H2 2014 127Number of Products by Top 10 Targets, H2 2014 128 www.aarkstore.com
Related Market Research reports: • Blirt S.A. - Product Pipeline Review – 2014 • Auris Medical Holding AG - Product Pipeline Review – 2014 • Integral Molecular, Inc. - Product Pipeline Review – 2014 • DaVinci Biosciences, LLC - Product Pipeline Review – 2014 • Actavis plc - Product Pipeline Review - 2014 www.aarkstore.com
Related Market Research reports: • TiGenix NV - Product Pipeline Review – 2014 • Egenix, Inc. - Product Pipeline Review – 2014 • SkyePharma PLC - Product Pipeline Review – 2014 • MediWound Ltd. - Product Pipeline Review – 2014 • BioTech Tools s.a. - Product Pipeline Review - 2014 www.aarkstore.com
Aarkstore - Crohns Disease - Pipeline Review, H2 2014 www.aarkstore.com
Contact Us Office Office No. - 809, 8th Floor, B-Wing, Mahaavir Icon, Plot No.- 89 & 90, Sector-15, CBD-Belapur, Navi Mumbai – 400614, Maharashtra, India. 24/7 Online Support: +91 9987295242 General Inquiries : +91 - 22 2756 4953 You Can Visit : http://www.aarkstore.com OR Mail us at : contact@aarkstore.com Blog : http://www.aarkstore.com/blog/ Conference : http://conference.aarkstore.com/ News : http://www.aarkstore.com/news www.aarkstore.com